Date published: 2026-5-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

Fenoldopam Mesylate (CAS 67227-57-0)

0.0(0)
Write a reviewAsk a question

Application:
Fenoldopam Mesylate is an anti-hypertensive, dopamine D1-receptor agonist
CAS Number:
67227-57-0
Molecular Weight:
401.86
Molecular Formula:
C16H16ClNO3•CH4O3S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

An anti-hypertensive, dopamine D1-receptor agonist.


Fenoldopam Mesylate (CAS 67227-57-0) References

  1. Renal blood flow changes induced with endothelin-1 and fenoldopam mesylate at quantitative Doppler US: initial results in a canine study.  |  Sehgal, CM., et al. 2001. Radiology. 219: 419-26. PMID: 11323466
  2. Effects of prophylactic fenoldopam infusion on renal blood flow and renal tubular function during acute hypovolemia in anesthetized dogs.  |  Halpenny, M., et al. 2001. Crit Care Med. 29: 855-60. PMID: 11373482
  3. N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity.  |  Briguori, C., et al. 2004. J Am Coll Cardiol. 44: 762-5. PMID: 15312855
  4. Preservation of renal blood flow during hypotension induced with fenoldopam in dogs.  |  Aronson, S., et al. 1990. Can J Anaesth. 37: 380-4. PMID: 1969772
  5. Ultrastructure of an arterial lesion induced in rats by fenoldopam mesylate, a dopaminergic vasodilator.  |  Bugelski, PJ., et al. 1989. Br J Exp Pathol. 70: 153-65. PMID: 2567179
  6. Pathogenesis of arterial lesions induced by dopaminergic compounds in the rat.  |  Kerns, WD., et al. 1989. Toxicol Pathol. 17: 203-13. PMID: 2568682
  7. Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat.  |  Kerns, WD., et al. 1989. Am J Pathol. 135: 339-49. PMID: 2571297
  8. Arterial medial necrosis and hemorrhage induced in rats by intravenous infusion of fenoldopam mesylate, a dopaminergic vasodilator.  |  Yuhas, EM., et al. 1985. Am J Pathol. 119: 83-91. PMID: 2858975
  9. Dopamine causes inhibition of Na+-K+-ATPase activity in rat proximal convoluted tubule segments.  |  Aperia, A., et al. 1987. Am J Physiol. 252: F39-45. PMID: 3028155
  10. Detection of fenoldopam-induced arteritis in rats using ex vivo / in vivo MRI.  |  Fujii, Y., et al. 2022. Toxicol Rep. 9: 1595-1602. PMID: 36518408
  11. Evaluation of in vivo MRI for detecting midodrine-induced arteritis in rats.  |  Fujii, Y., et al. 2023. Toxicol Rep. 10: 97-103. PMID: 36685272
  12. Characterization of the arteritis induced by infusion of rats with UK-61,260, an inodilator, for 24 h. A comparison with the arteritis induced by fenoldopam mesylate.  |  Hanton, G., et al. 1995. Arch Toxicol. 69: 698-704. PMID: 8572928
  13. Development of controlled-release SK&F 82526-J buffer bead formulations with tartaric acid as the buffer.  |  Venkatesh, GM. 1998. Pharm Dev Technol. 3: 477-85. PMID: 9834950
  14. The effect of fenoldopam on the blood pressure of the rat.  |  Quevedo, M., et al. 1999. Gen Pharmacol. 32: 123-5. PMID: 9888264

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Fenoldopam Mesylate, 10 mg

sc-211503
10 mg
$250.00